Compare Agora Inc (API) vs Nuvalent Inc (NUVL) Price & Performance

Agora, Inc. (API) trades at $4.17, down 1.18% today, with a bullish technical signal from moving averages. The company reported Q1 2026 earnings of $0.01 per share, beating expectations, and has achieved six consecutive quarters of GAAP profitability. Revenue for 2025 was $141.06 million, with a net income margin of 7.03%. The stock trades at a P/E of 47.84 and a P/B of 0.64, indicating a potentially undervalued asset relative to book value. Recent news highlights partnerships in AI-driven real-time engagement and voice intelligence.

The outlook for Agora is positive, supported by consistent earnings beats and growth in conversational AI demand. Key risks include gross margin contraction and competitive pressures in the tech sector. Analyst consensus is 60% buy, with no sell ratings, suggesting Wall Street optimism. Institutional interest is noted, but short interest increased by 30.3% in March 2026, indicating some skepticism.

Nuvalent (NUVL) trades at $123.90, up 0.06% on the day, as the stock approaches the $124 acquisition price from GSK's $10.6 billion buyout announced June 2026. The company shows negative profitability with ROE at -41.19% and net income of -$425.38M for 2025, but technical indicators remain bullish with strong moving average signals. Multiple law firms are investigating whether the acquisition price adequately values shareholders.

The investment outlook centers on the pending acquisition completion at $124 per share, offering minimal upside from current levels. Key risks include regulatory approval uncertainties and shareholder litigation challenging the deal terms. With negative earnings and cash flow, the stock's value is entirely acquisition-dependent rather than fundamental performance.